7G07

Crystal Structure of human FABP4 in complex with 4-[[3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]carbamoyl]-3,6-dihydro-2H-pyran-5-carboxylic acid

Experimental procedure

Experimental method	SINGLE WAVELENGTH
Source type	SYNCHROTRON
Source details	SLS BEAMLINE X10SA
Synchrotron site	SLS
Beamline	X10SA
Temperature [K]	100
Detector technology	PIXEL
Collection date	2012-06-04
Detector	PSI PILATUS 6M
Wavelength(s)	0.700010
Spacegroup name	P 21 21 21
Unit cell lengths	33.024, 54.276, 75.060
Unit cell angles	90.00, 90.00, 90.00

Refinement procedure

Resolution	30.890 - 1.610
R-factor	0.1947
Rwork	0.193
R-free	0.22950
Structure solution method	MOLECULAR REPLACEMENT
Starting model (for MR)	inhouse model
RMSD bond length	0.017
RMSD bond angle	1.926
Data reduction software	XDS
Data scaling software	XSCALE
Phasing software	PHASER
Refinement software	REFMAC (5.7.0025)

Data quality characteristics

	Overall	Inner shell	Outer shell
Low resolution limit [Å]	30.870	30.890	1.650
High resolution limit [Å]	1.610	7.200	1.610
Rmerge	0.072	0.025	1.447
Rmeas	0.082	0.028	1.583
Total number of observations	111481
Number of reflections	18144	244	1329
<I/σ(I)>	13.08	44.04	1.39
Completeness [%]	99.8	94.9	99.7
Redundancy	6.19	5.307	6
CC(1/2)	0.999	0.999	0.593

Crystallization Conditions

crystal ID	method	pH	temperature	details
1	VAPOR DIFFUSION, SITTING DROP	7	293	protein in 25mM Tris/HCl pH 7.5 100mM NaCl, see also PMID 27658368